188 related articles for article (PubMed ID: 36352396)
1. Inhibition of AEBP1 predisposes cisplatin-resistant oral cancer cells to ferroptosis.
Zhou Q; Wang X; Zhang Y; Wang L; Chen Z
BMC Oral Health; 2022 Nov; 22(1):478. PubMed ID: 36352396
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Glutaredoxin 5 predisposes Cisplatin-resistant Head and Neck Cancer Cells to Ferroptosis.
Lee J; You JH; Shin D; Roh JL
Theranostics; 2020; 10(17):7775-7786. PubMed ID: 32685019
[No Abstract] [Full Text] [Related]
3. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
Roh JL; Kim EH; Jang H; Shin D
Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
[TBL] [Abstract][Full Text] [Related]
4. Dihydrolipoamide dehydrogenase regulates cystine deprivation-induced ferroptosis in head and neck cancer.
Shin D; Lee J; You JH; Kim D; Roh JL
Redox Biol; 2020 Feb; 30():101418. PubMed ID: 31931284
[TBL] [Abstract][Full Text] [Related]
5. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.
Roh JL; Kim EH; Jang HJ; Park JY; Shin D
Cancer Lett; 2016 Oct; 381(1):96-103. PubMed ID: 27477897
[TBL] [Abstract][Full Text] [Related]
6. Adipocyte enhancer binding protein 1 (AEBP1) knockdown suppresses human glioma cell proliferation, invasion and induces early apoptosis.
Cheng L; Shao X; Wang Q; Jiang X; Dai Y; Chen S
Pathol Res Pract; 2020 Feb; 216(2):152790. PubMed ID: 31864713
[TBL] [Abstract][Full Text] [Related]
7. RBM15 silencing promotes ferroptosis by regulating the TGF-β/Smad2 pathway in lung cancer.
Feng J; Li Y; He F; Zhang F
Environ Toxicol; 2023 Mar; 38(4):950-961. PubMed ID: 36715115
[TBL] [Abstract][Full Text] [Related]
8. Shikonin and cisplatin synergistically overcome cisplatin resistance of ovarian cancer by inducing ferroptosis via upregulation of HMOX1 to promote Fe
Ni M; Zhou J; Zhu Z; Xu Q; Yin Z; Wang Y; Zheng Z; Zhao H
Phytomedicine; 2023 Apr; 112():154701. PubMed ID: 36773431
[TBL] [Abstract][Full Text] [Related]
9. AEBP1 promotes epithelial-mesenchymal transition of gastric cancer cells by activating the NF-κB pathway and predicts poor outcome of the patients.
Liu JY; Jiang L; Liu JJ; He T; Cui YH; Qian F; Yu PW
Sci Rep; 2018 Aug; 8(1):11955. PubMed ID: 30097586
[TBL] [Abstract][Full Text] [Related]
10. CISD2 inhibition overcomes resistance to sulfasalazine-induced ferroptotic cell death in head and neck cancer.
Kim EH; Shin D; Lee J; Jung AR; Roh JL
Cancer Lett; 2018 Sep; 432():180-190. PubMed ID: 29928961
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of adipocyte enhancer-binding protein 1 in endothelial cells promotes tumor angiogenesis in colorectal cancer.
Yorozu A; Yamamoto E; Niinuma T; Tsuyada A; Maruyama R; Kitajima H; Numata Y; Kai M; Sudo G; Kubo T; Nishidate T; Okita K; Takemasa I; Nakase H; Sugai T; Takano K; Suzuki H
Cancer Sci; 2020 May; 111(5):1631-1644. PubMed ID: 32086986
[TBL] [Abstract][Full Text] [Related]
12. AEBP1 Promotes Glioblastoma Progression and Activates the Classical NF-
Guo K; Song L; Chang J; Cao P; Liu Q
Behav Neurol; 2020; 2020():8890452. PubMed ID: 33224311
[TBL] [Abstract][Full Text] [Related]
13. AEBP1 down regulation induced cell death pathway depends on PTEN status of glioma cells.
Sinha S; Renganathan A; Nagendra PB; Bhat V; Mathew BS; Rao MRS
Sci Rep; 2019 Oct; 9(1):14577. PubMed ID: 31601918
[TBL] [Abstract][Full Text] [Related]
14. AEBP1, a prognostic indicator, promotes colon adenocarcinoma cell growth and metastasis through the NF-κB pathway.
Xing Y; Zhang Z; Chi F; Zhou Y; Ren S; Zhao Z; Zhu Y; Piao D
Mol Carcinog; 2019 Oct; 58(10):1795-1808. PubMed ID: 31219650
[TBL] [Abstract][Full Text] [Related]
15. AEBP1 upregulation confers acquired resistance to BRAF (V600E) inhibition in melanoma.
Hu W; Jin L; Jiang CC; Long GV; Scolyer RA; Wu Q; Zhang XD; Mei Y; Wu M
Cell Death Dis; 2013 Nov; 4(11):e914. PubMed ID: 24201813
[TBL] [Abstract][Full Text] [Related]
16. Piperlongumine rapidly induces the death of human pancreatic cancer cells mainly through the induction of ferroptosis.
Yamaguchi Y; Kasukabe T; Kumakura S
Int J Oncol; 2018 Mar; 52(3):1011-1022. PubMed ID: 29393418
[TBL] [Abstract][Full Text] [Related]
17. Adipocyte enhancer-binding protein 1 modulates adiposity and energy homeostasis.
Ro HS; Zhang L; Majdalawieh A; Kim SW; Wu X; Lyons PJ; Webber C; Ma H; Reidy SP; Boudreau A; Miller JR; Mitchell P; McLeod RS
Obesity (Silver Spring); 2007 Feb; 15(2):288-302. PubMed ID: 17299101
[TBL] [Abstract][Full Text] [Related]
18. Targeting of glioma stem-like cells with a parthenolide derivative ACT001 through inhibition of AEBP1/PI3K/AKT signaling.
Hou Y; Sun B; Liu W; Yu B; Shi Q; Luo F; Bai Y; Feng H
Theranostics; 2021; 11(2):555-566. PubMed ID: 33391492
[TBL] [Abstract][Full Text] [Related]
19. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
Shin D; Kim EH; Lee J; Roh JL
Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
[TBL] [Abstract][Full Text] [Related]
20. Attenuating the abnormally high expression of AEBP1 suppresses the pathogenesis of childhood acute lymphoblastic leukemia via p53-dependent signaling pathway.
Li S; Juan CX; Feng AM; Bian HL; Liu WD; Zhang GQ; Wang CZ; Cao Q; Zhou GP
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1184-1195. PubMed ID: 30779088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
